Literature DB >> 18984471

Immune interactions in hepatic fibrosis.

Andrew P Holt1, Mike Salmon, Christopher D Buckley, David H Adams.   

Abstract

Liver cirrhosis is caused by iterative cycles of tissue injury, inflammation, and repair. Although most causes of acute hepatitis resolve without scarring, chronic hepatitis is associated with persistent inflammation and matrix remodeling, which leads to fibrosis and, eventually, cirrhosis. The mechanisms that govern wound healing involve interactions between the innate and adaptive immune systems and stromal cells within a microenvironment composed of cytokines, growth factors, and modified matricellular proteins. The immune system plays a central role in the regulation of fibrosis, tissue repair, and recovery that is vital for the maintenance of tissue homeostasis. Chronic inflammation and fibrosis are inextricably linked and the cellular interactions between immune effector cells, local fibroblasts, and tissue macrophages at sites of scar formation determine the outcome of liver injury and the development of scarring.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18984471      PMCID: PMC2605646          DOI: 10.1016/j.cld.2008.07.002

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  146 in total

1.  Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice.

Authors:  J Tian; D Zekzer; L Hanssen; Y Lu; A Olcott; D L Kaufman
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

2.  Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells.

Authors:  F Marra; R G Romanelli; C Giannini; P Failli; S Pastacaldi; M C Arrighi; M Pinzani; G Laffi; P Montalto; P Gentilini
Journal:  Hepatology       Date:  1999-01       Impact factor: 17.425

3.  Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts.

Authors:  Kumiko Isse; Kenichi Harada; Yoh Zen; Takashi Kamihira; Shinji Shimoda; Mine Harada; Yasuni Nakanuma
Journal:  Hepatology       Date:  2005-03       Impact factor: 17.425

Review 4.  The scarring of the liver acini (Cirrhosis). Tridimensional and microcirculatory considerations.

Authors:  A M Rappaport; P J MacPhee; M M Fisher; M J Phillips
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

5.  Coculture of human liver macrophages and cholangiocytes leads to CD40-dependent apoptosis and cytokine secretion.

Authors:  Edward B Alabraba; Vincent Lai; Louis Boon; Stephen J Wigmore; David H Adams; Simon C Afford
Journal:  Hepatology       Date:  2008-02       Impact factor: 17.425

Review 6.  Liver fibrosis: from the bench to clinical targets.

Authors:  M Pinzani; K Rombouts
Journal:  Dig Liver Dis       Date:  2004-04       Impact factor: 4.088

7.  Interleukin-10 secretion differentiates dendritic cells from human liver and skin.

Authors:  Sarah Goddard; Janine Youster; Emma Morgan; David H Adams
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

8.  CXC chemokine ligand 16 promotes integrin-mediated adhesion of liver-infiltrating lymphocytes to cholangiocytes and hepatocytes within the inflamed human liver.

Authors:  Mathis Heydtmann; Patricia F Lalor; J Albertus Eksteen; Stefan G Hübscher; Mike Briskin; David H Adams
Journal:  J Immunol       Date:  2005-01-15       Impact factor: 5.422

9.  Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage.

Authors:  Claire Dunn; Maurizia Brunetto; Gary Reynolds; Theodoros Christophides; Patrick T Kennedy; Pietro Lampertico; Abhishek Das; A Ross Lopes; Persephone Borrow; Kevin Williams; Elizabeth Humphreys; Simon Afford; David H Adams; Antonio Bertoletti; Mala K Maini
Journal:  J Exp Med       Date:  2007-03-12       Impact factor: 14.307

10.  Scavenger properties of cultivated pig liver endothelial cells.

Authors:  Kjetil H Elvevold; Geir I Nedredal; Arthur Revhaug; Bård Smedsrød
Journal:  Comp Hepatol       Date:  2004-08-12
View more
  47 in total

1.  SHP-dependent and -independent induction of peroxisome proliferator-activated receptor-γ by the bile acid sensor farnesoid X receptor counter-regulates the pro-inflammatory phenotype of liver myofibroblasts.

Authors:  Barbara Renga; Andrea Mencarelli; Marco Migliorati; Sabrina Cipriani; Claudio D'Amore; Eleonora Distrutti; Stefano Fiorucci
Journal:  Inflamm Res       Date:  2011-01-29       Impact factor: 4.575

2.  Interleukin-22 ameliorates liver fibrogenesis by attenuating hepatic stellate cell activation and downregulating the levels of inflammatory cytokines.

Authors:  Dong-Hong Lu; Xiao-Yun Guo; Shan-Yu Qin; Wei Luo; Xiao-Li Huang; Mei Chen; Jia-Xu Wang; Shi-Jia Ma; Xian-Wen Yang; Hai-Xing Jiang
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

3.  Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells.

Authors:  Miroslaw Kornek; Yury Popov; Towia A Libermann; Nezam H Afdhal; Detlef Schuppan
Journal:  Hepatology       Date:  2010-10-26       Impact factor: 17.425

4.  Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice.

Authors:  Marie-Luise Berres; Rory R Koenen; Anna Rueland; Mirko Moreno Zaldivar; Daniel Heinrichs; Hacer Sahin; Petra Schmitz; Konrad L Streetz; Thomas Berg; Nikolaus Gassler; Ralf Weiskirchen; Amanda Proudfoot; Christian Weber; Christian Trautwein; Hermann E Wasmuth
Journal:  J Clin Invest       Date:  2010-10-18       Impact factor: 14.808

5.  Evaluation of risk factors for the development of cirrhosis in autoimmune hepatitis: Japanese NHO-AIH prospective study.

Authors:  Kiyoshi Migita; Yukio Watanabe; Yuka Jiuchi; Yoko Nakamura; Akira Saito; Michiyasu Yagura; Hideo Morimoto; Masaaki Shimada; Eiji Mita; Taizo Hijioka; Haruhiro Yamashita; Eiichi Takezaki; Toyokichi Muro; Hironori Sakai; Makoto Nakamuta; Seigo Abiru; Koji Yano; Atsumasa Komori; Hiroshi Yatsuhashi; Minoru Nakamura; Hiromi Ishibashi
Journal:  J Gastroenterol       Date:  2010-11-02       Impact factor: 7.527

6.  Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions.

Authors:  David J Orlicky; Andrew E Libby; Elise S Bales; Rachel H McMahan; Jenifer Monks; Francisco G La Rosa; James L McManaman
Journal:  J Physiol       Date:  2019-01-02       Impact factor: 5.182

7.  Bone morphogenetic protein 4 provides cancer-supportive phenotypes to liver fibroblasts in patients with hepatocellular carcinoma.

Authors:  Yohei Mano; Sachiyo Yoshio; Hirotaka Shoji; Shimagaki Tomonari; Yoshihiko Aoki; Nobuyoshi Aoyanagi; Toru Okamoto; Yoshiharu Matsuura; Yosuke Osawa; Kiminori Kimura; Kyohei Yugawa; Huanlin Wang; Yoshinao Oda; Tomoharu Yoshizumi; Yoshihiko Maehara; Tatsuya Kanto
Journal:  J Gastroenterol       Date:  2019-04-02       Impact factor: 7.527

Review 8.  New insights into Nod-like receptors (NLRs) in liver diseases.

Authors:  Tao Xu; Yan Du; Xiu-Bin Fang; Hao Chen; Dan-Dan Zhou; Yang Wang; Lei Zhang
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2018-03-10

9.  Activated rat hepatic stellate cells influence Th1/Th2 profile in vitro.

Authors:  Zhi-Zhi Xing; Liu-Ye Huang; Cheng-Rong Wu; Hong You; Hong Ma; Ji-Dong Jia
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

10.  Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis.

Authors:  Jinsheng Guo; Scott L Friedman
Journal:  Fibrogenesis Tissue Repair       Date:  2010-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.